Abstract

BackgroundGiven the great technical difficulty and procedural complexity of laparoscopic total gastrectomy (LTG), the technical and oncologic safety of LTG versus open total gastrectomy (OTG) in the field of advanced gastric cancer (AGC) is yet undetermined.ObjectiveThis multicenter cohort study aimed to compare the surgical and oncological outcomes of LTG with those of OTG in AGC patients.Patients and MethodsIn total, 588 patients from 3 centers who underwent primary total gastrectomy with D2 lymphadenectomy, by well-trained surgeons with adequate experience, for pathologically confirmed locally AGC (T2N0–3, T3N0–3, or T4N0–3) between January 1, 2011, and December 31, 2015, were identified, and their clinical data were collected from three participating centers. After 1:1 propensity score matching (PSM), 450 cases (LTG, n = 225; OTG, n = 225) were eligible and assessed.ResultsNo significant difference in the number of retrieved lymph nodes, 5-year disease-free survival (DFS) rates, or 5-year overall survival (OS) rates between both surgical groups were observed. Although LTG had significantly longer surgical time (262 vs. 180 min, p < 0.001), LTG was associated with fewer postoperative complications [relative risk (RR) 0.583, 95% CI 0.353–0.960, p = 0.047), less intraoperative bleeding (120 vs. 200 ml, p < 0.001), longer proximal margin resection (3 vs. 2 cm, p < 0.001), and shorter postoperative hospitalization (11 vs. 13 days, p < 0.001). The mortality rate was comparable in both groups.ConclusionsLTG was not inferior to OTG in terms of survival outcomes and was associated with shorter surgical and postoperative hospitalization time and fewer postoperative complications, suggesting LTG with D2 lymphadenectomy as an important alternative to OTG for patients with AGC, but to be carried out in highly experienced centers.

Highlights

  • Gastric cancer is still one of the most common and lethal cancers worldwide and in China [1, 2]

  • laparoscopic total gastrectomy (LTG) was associated with significantly longer surgical time (262 vs. 180 min, p < 0.001)

  • There was no significant difference in the status of proximal or distal resection margin, the number of retrieved lymph nodes, time to first liquid, or time to ambulation found between the two groups

Read more

Summary

Introduction

Gastric cancer is still one of the most common and lethal cancers worldwide and in China [1, 2]. In regard to early gastric cancer (EGC), only two multicenter randomized clinical trials (RCTs), KLASS03 [6] and CLASS02 [7], have established the feasibility and safety of laparoscopic total gastrectomy (LTG), and studies on the oncological safety of LTG are still ongoing. The safety of LTG for advanced gastric cancer (AGC) remains uncertain in the absence of high-level clinical evidence from RCTs. satisfactory surgical and oncological outcomes from LTG for AGC have been reported by several studies [8,9,10,11,12,13,14,15], they are limited due to almost exclusively being retrospective studies of small sample sizes from single centers. Given the great technical difficulty and procedural complexity of laparoscopic total gastrectomy (LTG), the technical and oncologic safety of LTG versus open total gastrectomy (OTG) in the field of advanced gastric cancer (AGC) is yet undetermined

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call